Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul 24;390(4):775-90.
doi: 10.1016/j.jmb.2009.05.066. Epub 2009 May 27.

Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy

Affiliations

Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy

Christina R Bodner et al. J Mol Biol. .

Abstract

'In dopaminergic neurons, alpha-synuclein (alphaS) partitions between a disordered cytosolic state and a lipid-bound state. Binding of alphaS to membrane phospholipids is implicated in its functional role in synaptic regulation, but also impacts fibril formation associated with Parkinson's disease. We describe here a solution NMR study in which alphaS is added to small unilamellar vesicles of a composition mimicking synaptic vesicles; the results provide evidence for multiple distinct phospholipid-binding modes of alphaS. Exchange between the free state and the lipid-bound alphaS state, and between different bound states is slow on the NMR timescale, being in the range of 1-10 s(-1). Partitioning of the binding modes is dependent on lipid/alphaS stoichiometry, and tight binding with slow-exchange kinetics is observed at stoichiometries as low as 2:1. In all lipid-bound states, a segment of residues starting at the N-terminus of alphaS adopts an alpha-helical conformation, while succeeding residues retain the characteristics of a random coil. The 40 C-terminal residues remain dynamically disordered, even at high-lipid concentrations, but can also bind to lipids to an extent that appears to be determined by the fraction of cis X-Pro peptide bonds in this region. While lipid-bound alphaS exhibits dynamic properties that preclude its direct observation by NMR, its exchange with the NMR-visible free form allows for its indirect characterization. Rapid amide-amide nuclear Overhauser enhancement buildup points to a large alpha-helical conformation, and a distinct increase in fluorescence anisotropy attributed to Tyr39 indicates an ordered environment for this "dark state." Titration of alphaS with increasing amounts of lipids suggests that the binding mode under high-lipid conditions remains qualitatively similar to that in the low-lipid case. The NMR data appear incompatible with the commonly assumed model where alphaS lies in an alpha-helical conformation on the membrane surface and instead suggest that considerable remodeling of the vesicles is induced by alphaS.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effects of addition of lipid SUVs on the 1H-15N HSQC spectrum of αS, recorded at a 1H frequency of 600 MHz, 293 K, pH 6.0. (a) A section from the assigned and overlaid HSQC spectra of 150 μM αS in the presence of 0.03% (black) or 0.06% SUV (red). (b) Fractional signal attenuation relative to lipid-free spectra as a function of residue number for 150 μM αS in the presence of 0.03% SUV (w/v). The lipid: αS molar ratio is 2.6:1. Missing values correspond to proline residues (marked by arrows), two solvent-exchanged N-terminal residues, and residues whose 1H/15N cross peaks are significantly overlapped, which have been eliminated from further analysis.
Fig. 2
Fig. 2
Impact of αS-lipid binding on 1H-15N HSQC cross peak intensity and line width under lipid-limited and lipid-saturated conditions. (a) In the presence of 0.03% SUV, NMR cross peak signal attenuation profiles for decreasing concentrations of αS are shown: 150 μM (blue), 75 μM (green), 25 μM (red), and 12.5 μM (black). (b) Attenuation profile for 150 μM αS in the presence of 2.0% SUV, where the lipid: αS ratio is 173:1. Cross peak intensities of residues preceding V52 were too weak for reliable measurements. Decreased αS concentration or increased lipid availability reduces competition between different binding modes, altering the attenuation profile. Upon lowering the αS concentration, no significant changes to the profile are observed for lipid: αS ratios > 15, where binding appears no longer constrained by the lipid-limited condition. (c) 1H (filled circles) and 15N (open circles) line widths for the same 25 μM αS sample used for data in panel (a). Narrow and uniform line widths show that observed signals correspond to amide groups of residues in the random coil state.
Fig. 3
Fig. 3
Fluorescence anisotropy, r, of 500 μM αS as a function of lipid concentration. The emission maximum of tyrosine, 306 nm, is monitored. At the lipid concentration of 0.1%, where the lipid: αS ratio is 2.6:1, the change in fluorescence anisotropy nears saturation.
Fig. 4
Fig. 4
Transverse relaxation rates of the 15N TROSY component (R2T) measured for 600 μM αS in the presence (black) and absence (red) of 0.03% SUV, measured at 600 MHz 1H frequency. In the presence of lipids, the effective R2T is the sum of the intrinsic R2T and the forward exchange rate, kon. Rates are derived from the mono-exponential fitting of intensities recorded in an interleaved manner for twelve transverse decay times: 20, 30, 50, 70, 90, 120, 150, 180, 220, 270, 400, and 500 ms.
Fig. 5
Fig. 5
Lipid to αS NOE magnetization transfer as monitored by fractional attenuation of the 1H-15N HSQC intensities, when the HSQC spectrum is preceded by selective saturation of phospholipid methylene resonance at 1.16 ppm. The sample contains 150 μM perdeuterated αS and 0.03% SUV. The spectra with and without lipid saturation are recorded in an interleaved mode, applying a 1.5 s presaturation with a 21 Hz RF field strength at either 1.16 ppm or at −10.0 ppm . The strongest NOE transfer is observed for N-terminal residues which also exhibit the highest signal attenuation, indicative of highest partitioning into the “dark state”. Error bars correspond to the estimated uncertainty calculated from the signal-to-noise ratio of each correlation.
Fig. 6
Fig. 6
Series of strip plots for residues 77-90, taken orthogonal to the 1H frequency axis of a 600-MHz 3D HMQC-NOESY-HMQC spectrum labeled with 15N frequencies in both F1 and F2 dimensions, recorded for 600 μM αS in the presence of 0.03% SUV and using a 100 ms NOE mixing time. The use of two 15N dimensions in this experiment capitalizes on the greater dispersion of 15N frequencies relative to 1H frequencies to resolve ambiguities in the poorly dispersed spectrum of αS. Spin diffusion undergone by αS in the helical bound state manifests itself in the extensive i to i ± n amide cross peaks.
Fig. 7
Fig. 7
NOE effect from Leu-Cδ1 H3 methyl groups to backbone amide protons, as monitored by the intensity of 15N-1H HSQC correlations for a sample of 600 μM (I,L,V)- αS in the presence of 0.06% SUV, when the 15N-1H HSQC spectrum is preceded by the selective inversion or non-inversion of the Leu Cδ1 methyl protons (see Methods), using a 250 ms NOE mixing period. The protein is uniformly enriched in 15N and 2H, with selectively-labeled 13C1H3 groups for Ile, Leu, and Val. (a) Section of the difference HSQC spectrum showing differential intensities of leucine and their sequentially adjacent residues. (b) Corresponding histogram plotting the fractional change in signal intensity as a function of protein sequence; positions of leucine residues are marked by arrows.
Fig. 8
Fig. 8
Cryo EM images for a sample of 0.03% DOPE:DOPS:DOPC SUVs in the absence (a) and presence (b-d) of 600 μM αS. In the absence of αS, vesicles are relatively uniform, 20–40 nm in diameter. Destabilization of the vesicle by αS interaction results in gross rearrangements, with the formation of large, multilamellar (b), tubular (c), and pinched, branched, and tubular structures (d). The dark ridges in the top left of (a) and (d) and bottom left of (c) correspond to the boundaries of the carbon support of the grid.
Fig. 9
Fig. 9
Pulsed field gradient diffusion plots for αS and SUVs, isolated and in mixed samples. 150 μM αS in absence of lipid (open circles), and in the presence of 0.03% (grey circles) or 2.0% (black circles) lipid. 2.0% DOPE:DOPS:DOPC SUV in the absence (open squares) of αS. The plot for free αS shows a linear correlation, while all other series show differing degrees of non-linearity attributable to the heterogeneity of the species being measured. Diffusion delays of 500ms were used and for αS the signal decay of the entire amide envelope region is used for intensity measurement. For the 150 μM αS/0.03% SUV sample, 68% of the observed total intensity corresponds to lipid-free protein (note that for lipid-bound protein, only about half of the residues yield observable intensity). Plotted is the natural logarithm of the ratio between the observed total amide proton intensity, I, and the value Io measured at 6% of maximum gradient strength (87 G/cm), i.e., Go = 5.2 G/cm. In order to avoid contamination from direct solvent exchange with amide protons, data were recorded at pH 6.0, 10 °C.

References

    1. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A. 1998;95:6469–6473. - PMC - PubMed
    1. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. alpha-synuclein in Lewy bodies. Nature. 1997;388:839–840. - PubMed
    1. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, DiIorio G, Golbe LI, Nussbaum RL. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045–2047. - PubMed
    1. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nature Genetics. 1998;18:106–108. - PubMed
    1. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Tortosa EG, del Ser T, Munoz DG, de Yebenes JG. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Annals of Neurology. 2004;55:164–173. - PubMed

Publication types

LinkOut - more resources